Pharmacopeia, Inc. (NASDAQ:PCOP)

CAPS Rating: No stars

A biopharmaceutical company committed to discovering and developing novel therapeutics to address medical needs.

Recs

0
Player Avatar myersfield (< 20) Submitted: 9/20/2007 2:48:50 PM : Outperform Start Price: $5.42 PCOP Score: -59.13

Strong partnerships.

Report this Post Reply

Featured Broker Partners


Advertisement